CCEL

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: BTMD DCGO PIII JYNT PARK WW AIRS GMRS LFST MD

Scroll to Statements

Index	-
Market Cap	29.40M
Enterprise Value	37.21M
Income	-2.67M
Sales	31.28M
Book/sh	-2.28
Cash/sh	0.36
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	May 21, 2025
Dividend Gr. 3/5Y	- -
Payout	-
Employees	76
IPO	Apr 04, 1994

P/E	-
Forward P/E	182.50
PEG	-
P/S	0.94
P/B	-
P/C	10.14
P/FCF	5.95
EV/EBITDA	23.85
EV/Sales	1.19
Quick Ratio	0.60
Current Ratio	0.62
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-0.33
EPS next Y	0.02
EPS next Q	0.00
EPS this Y	136.67%
EPS next Y	-81.82%
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	1.33% 0.27%
EPS Y/Y TTM	-2181.76%
Sales Y/Y TTM	-2.56%
EPS Q/Q	-83.19%
Sales Q/Q	-3.59%
Earnings	Apr 14 AMC
EPS/Sales Surpr.	150.00% -0.26%

Insider Own	47.91%
Insider Trans	0.00%
Inst Own	13.45%
Inst Trans	-29.28%
ROA	-4.26%
ROE	-
ROIC	-
Gross Margin	75.09%
Oper. Margin	0.61%
Profit Margin	-8.52%
SMA20	3.15%
SMA50	3.67%
SMA200	-1.68%
Trades

Shs Outstand	8.06M
Shs Float	4.20M
Short Float	0.15%
Short Ratio	0.67
Short Interest	0.01M
52W High	5.43 -32.78%
52W Low	2.72 34.19%
Volatility	7.95% 8.38%
ATR (14)	0.30
RSI (14)	53.02
Beta	0.47
Rel Volume	0.70
Avg Volume	9.52K
Volume	1,429

Perf Week	1.11%
Perf Month	0.55%
Perf Quarter	5.19%
Perf Half Y	1.11%
Perf YTD	6.11%
Perf Year	-23.96%
Perf 3Y	-45.68%
Perf 5Y	-54.06%
Perf 10Y	3.94%
Recom	1.00
Target Price	8.50
Prev Close	3.42
Price	3.65
Change	6.73%

May-08-26 04:00PM	Cryo-Cell Receives Acceptance of Compliance Plan From NYSE American (Business Wire)
Apr-28-26 04:00PM	Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks (Business Wire) -14.95%
Mar-12-26 05:00PM	Cryo-Cell Receives NYSE American Continued Listing Notice (Business Wire) -6.11%
Feb-27-26 05:00PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025 (Business Wire)
Aug-14-25 08:30AM	Cryo-Cell International, Inc. Provides Dividend Update (Business Wire) -9.67%
05:00PM	Loading…
Jul-15-25 05:00PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results (Business Wire)
May-08-25 05:00PM	Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend (Business Wire)
Apr-16-25 11:59AM	Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz (TipRanks) +9.48%
Apr-15-25 08:30AM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results (Business Wire)
Jan-29-25 04:15PM	Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives (Business Wire)
Oct-30-24 08:45AM	Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend (Business Wire) +25.60%
Oct-15-24 05:20PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results (Business Wire) +6.98%
Jul-15-24 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results (Business Wire) -6.07%
Apr-15-24 05:00PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results (Business Wire) -5.37%
Mar-25-24 09:00AM	Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value (Business Wire) +7.64%
05:00PM	Loading…
Feb-28-24 05:00PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023 (Business Wire)
Jan-22-24 04:15PM	Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET (GlobeNewswire)
Oct-12-23 04:45PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results (Business Wire)
Jul-14-23 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results (Business Wire) -9.50%
Apr-21-23 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results (Business Wire) +14.74%
Feb-28-23 05:15PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022 (GlobeNewswire)
Jan-24-23 11:00AM	Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET (GlobeNewswire)
Oct-14-22 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results (GlobeNewswire)
Aug-22-22 06:00PM	Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend (GlobeNewswire) +15.38%
Aug-17-22 05:00PM	Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange (GlobeNewswire) +10.36% -7.65%
Jul-11-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results (GlobeNewswire)
Apr-13-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results (GlobeNewswire)
Mar-16-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service (GlobeNewswire)
Mar-09-22 04:15PM	Cryo-Cell Shares Its 2021 Annual Letter to Shareholders (GlobeNewswire)
Feb-22-22 04:30PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021 (GlobeNewswire) +7.00% -10.03%
04:15PM	Loading…
Oct-27-21 04:15PM	Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials (GlobeNewswire)
Oct-15-21 04:36PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results (GlobeNewswire)
Sep-20-21 06:05PM	Cryo-Cell International Announces Changes To Its Board of Directors (GlobeNewswire) -5.45% +6.51%
Aug-30-21 09:00AM	Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market (GlobeNewswire) +7.82%
Aug-20-21 09:04AM	Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies (GlobeNewswire)
Aug-11-21 12:03PM	Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021 (Newsfile)
09:00AM	Cryo-Cell International to Present at the Q3 Virtual Investor Summit (GlobeNewswire)
Jul-15-21 07:27PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results (GlobeNewswire)
May-10-21 09:00AM	Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials (GlobeNewswire)
Apr-14-21 06:14PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2021 Financial Results (GlobeNewswire)
Feb-26-21 09:30AM	Cord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement with Duke University (GlobeNewswire) +11.11%
Feb-24-21 04:30PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2020 (GlobeNewswire)
Oct-15-20 04:39PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2020 Financial Results (GlobeNewswire)

Cryo-Cell International, Inc. is a cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Umbilical Cord Blood and Cord Tissue Stem Cell Service, PrepaCyte CB, and Public Cord Blood Banking. The Umbilical Cord Blood and Cord Tissue Stem Cell Service segment refers to cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use. The PrepaCyte CB segment focuses on the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells. The Public Cord Blood Banking segment relates to the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company was founded in 1989 and is headquartered in Oldsmar, FL.

Chairman & Co-CEOMr. David I. Portnoy

Co-CEO & DirectorMr. Mark L. Portnoy

CFO & VP of FinanceMs. Jill M. Taymans

Chief Information OfficerMr. Oleg Mikulinsky

Medical Director and Member of Medical & Scientific Advisory BoardDr. Joanne Kurtzberg M.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
TAYMANS JILL M	VP Finance, CFO	May 28 '26	Option Exercise	3.10	7,500	23,250	52,896	May 29 04:30 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 16 '25	Buy	4.46	6,449	28,763	818,369	Sep 18 04:53 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 17 '25	Buy	4.43	5,564	24,649	823,933	Sep 18 04:53 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 18 '25	Buy	4.46	3,411	15,213	827,344	Sep 18 04:53 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 18 '25	Buy	4.49	1,751	7,862	161,833	Sep 18 04:53 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 10 '25	Buy	4.44	25,139	111,692	268,878	Sep 10 05:22 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 10 '25	Buy	4.42	7,178	31,727	811,920	Sep 10 05:22 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 09 '25	Buy	4.49	5,312	23,849	257,843	Sep 10 05:22 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 08 '25	Buy	4.31	5,271	22,718	253,028	Sep 10 05:22 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 25 '25	Buy	4.61	14,000	64,560	241,539	Aug 27 05:23 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 27 '25	Buy	4.43	14,078	62,349	247,757	Aug 27 05:23 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 26 '25	Buy	4.44	11,101	49,288	156,322	Aug 27 05:23 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 18 '25	Buy	4.37	9,327	40,759	134,836	Aug 19 05:00 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 15 '25	Buy	4.45	9,089	40,451	237,039	Aug 19 05:00 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 19 '25	Buy	4.37	885	3,867	135,721	Aug 19 05:00 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 14 '25	Buy	4.17	5,826	24,305	122,838	Aug 18 05:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Cryo-Cell International Inc

Upgrade your Finviz experience